These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19363132)

  • 1. Clinical cardioprotection and the value of conditioning responses.
    Peart JN; Headrick JP
    Am J Physiol Heart Circ Physiol; 2009 Jun; 296(6):H1705-20. PubMed ID: 19363132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioprotection techniques: preconditioning, postconditioning and remote conditioning (basic science).
    Hausenloy DJ
    Curr Pharm Des; 2013; 19(25):4544-63. PubMed ID: 23270554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in Pharmacological and Non-Pharmacological Strategies of Cardioprotection.
    Caricati-Neto A; Errante PR; Menezes-Rodrigues FS
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Realizing the clinical potential of ischemic preconditioning and postconditioning.
    Yellon DM; Hausenloy DJ
    Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):568-75. PubMed ID: 16258568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healing the diabetic heart: does myocardial preconditioning work?
    Balakumar P; Sharma NK
    Cell Signal; 2012 Jan; 24(1):53-9. PubMed ID: 21945408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State of the science of cardioprotection: Challenges and opportunities--proceedings of the 2010 NHLBI Workshop on Cardioprotection.
    Kloner RA; Schwartz Longacre L
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):223-32. PubMed ID: 21821520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological Conditioning of the Heart: An Update on Experimental Developments and Clinical Implications.
    Roth S; Torregroza C; Feige K; Preckel B; Hollmann MW; Weber NC; Huhn R
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic pharmacological preconditioning against ischemia.
    Luca MC; Liuni A; Muxel S; Münzel T; Forconi S; Gori T; Parker JD
    Clin Hemorheol Microcirc; 2011; 49(1-4):287-93. PubMed ID: 22214700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotection: chances and challenges of its translation to the clinic.
    Heusch G
    Lancet; 2013 Jan; 381(9861):166-75. PubMed ID: 23095318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotection from ischemia/reperfusion injury: basic and translational research.
    Minamino T
    Circ J; 2012; 76(5):1074-82. PubMed ID: 22504127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protecting the heart from ischemia: an update on ischemic and pharmacologic conditioning.
    Gerczuk PZ; Kloner RA
    Hosp Pract (1995); 2011 Aug; 39(3):35-43. PubMed ID: 21881390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiology and pharmacology of myocardial preconditioning and postconditioning.
    Huffmyer J; Raphael J
    Semin Cardiothorac Vasc Anesth; 2009 Mar; 13(1):5-18. PubMed ID: 19329471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning.
    Heusch G
    Circ Res; 2015 Feb; 116(4):674-99. PubMed ID: 25677517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cGMP-Elevating Compounds and Ischemic Conditioning Provide Cardioprotection Against Ischemia and Reperfusion Injury via Cardiomyocyte-Specific BK Channels.
    Frankenreiter S; Bednarczyk P; Kniess A; Bork NI; Straubinger J; Koprowski P; Wrzosek A; Mohr E; Logan A; Murphy MP; Gawaz M; Krieg T; Szewczyk A; Nikolaev VO; Ruth P; Lukowski R
    Circulation; 2017 Dec; 136(24):2337-2355. PubMed ID: 29051185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures.
    Sanada S; Komuro I; Kitakaze M
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1723-41. PubMed ID: 21856909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous Cardioprotective Agents: Role in Pre and Postconditioning.
    Penna C; Granata R; Tocchetti CG; Gallo MP; Alloatti G; Pagliaro P
    Curr Drug Targets; 2015; 16(8):843-67. PubMed ID: 25751010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival.
    Kim HS; Cho JE; Hwang KC; Shim YH; Lee JH; Kwak YL
    Eur J Pharmacol; 2010 Feb; 628(1-3):132-9. PubMed ID: 19944681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Findings and Therapeutic Targets on Cardioprotection of Ischemia/ Reperfusion Injury in STEMI.
    Li J; Sun D; Li Y
    Curr Pharm Des; 2019; 25(35):3726-3739. PubMed ID: 31692431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical Issues for the Translation of Cardioprotection.
    Heusch G
    Circ Res; 2017 Apr; 120(9):1477-1486. PubMed ID: 28450365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.